|
64
|
321
|
3s12A |
Crystal structure of h5n1 influenza virus hemagglutinin, strain yu562 crystal form 1 |
|
34
|
186
|
3sw0X |
Structure of the c-terminal region (modules 18-20) of complement regulator factor h |
|
71
|
277
|
3s13A |
Crystal structure of h5n1 influenza virus hemagglutinin, strain yu562 crystal form 2 |
|
12
|
56
|
3sw2A |
X-ray crystal structure of human fxa in complex with 6-chloro-n-((3s)-2-oxo-1-(2-oxo-2-((5s)-8-oxo-5,6-dihydro-1h-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2h,4h,8h)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide |
|
16
|
82
|
3s8vX |
Crystal structure of lrp6-dkk1 complex |
|
75
|
322
|
3s11A |
Crystal structure of h5n1 influenza virus hemagglutinin, strain 437-10 |
|
47
|
245
|
3s04A |
Crystal structure of escherichia coli type i signal peptidase in complex with an arylomycin lipoglycopeptide antibiotic |
|
52
|
279
|
1ywhA |
Crystal structure of urokinase plasminogen activator receptor |
|
173
|
561
|
5lktA |
Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme a. |
|
166
|
558
|
5lkuA |
Crystal structure of the p300 acetyltransferase catalytic core with coenzyme a. |
|
170
|
560
|
5lkxA |
Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme a. |
|
164
|
561
|
5lkzA |
Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme a. |
|
12
|
55
|
5l2yL |
Factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19-hexaen-7-yl] cyclobutane-1-carboxylic acid |
|
195
|
551
|
5kirA |
The structure of vioxx bound to human cox-2 |
|
23
|
161
|
5l36B |
Crystal structure of a human fasl mutant in complex with human dcr3 |
|
5
|
40
|
5kn5C |
Tgfalpha/epiregulin complex with neutralizing antibody ly3016859 |
|
71
|
262
|
5kswB |
Dhodb-i74d mutant |
|
13
|
56
|
5l30L |
Factor viia in complex with the inhibitor (2r,15r)-2-[(1-aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1h-tetrazol-5-yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
13
|
58
|
5l2zL |
Factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-7-yl]cyclohexane-1-carboxylic acid |
|
16
|
110
|
5jz7A |
Ngf in complex with medi578 scfv |
|
200
|
552
|
5jw1A |
Crystal structure of celecoxib bound to s121p murine cox-2 mutant |
|
195
|
551
|
5jvyA |
Crystal structure of s121p murine cox-2 mutant |
|
67
|
321
|
5jw4A |
Structure of medi8852 fab fragment in complex with h5 ha |
|
10
|
51
|
5k0hB |
Human factor xa in complex with synthetic inhibitor benzylsulfonyl-dser(benzyl)-gly-4-amidinobenzylamide |
|
200
|
552
|
5jvzA |
Crystal structure of flurbiprofen bound to s121p murine cox-2 mutant |
|
25
|
145
|
5jpmG |
Structure of the complex of human complement c4 with masp-2 rebuilt using imdff |
|
11
|
51
|
5jb9E |
Crystal structure of factor ixa k98t variant in complex with ppack |
|
8
|
51
|
5jbcE |
Crystal structure of factor ixa variant v16i k98t y177t i213v in complex with ppack |
|
11
|
51
|
5jbbE |
Crystal structure of factor ixa variant v16i k98t y177t i213v in complex with egr-chloromethylketone |
|
10
|
51
|
5jb8E |
Crystal structure of factor ixa variant k98t in complex with egr-chloromethylketone |
|
9
|
67
|
5j4sB |
Alpha-chymotrypsin from bovine pancreas in complex with a modified bowman-birk inhibitor from soybean |
|
192
|
551
|
5ikqA |
The structure of meclofenamic acid bound to human cyclooxygenase-2 |
|
200
|
551
|
5ikvA |
The structure of flufenamic acid bound to human cyclooxygenase-2 |
|
203
|
551
|
5iktA |
The structure of tolfenamic acid bound to human cyclooxygenase-2 |
|
18
|
77
|
5imtD |
Toxin receptor complex |
|
22
|
168
|
5ihlA |
Structure of the extracellular domain of the cd40 in complex with 3h56-5 dab |
|
16
|
78
|
5imyC |
Trapped toxin |
|
63
|
303
|
5iblB |
Human antibody 6639 in complex with influenza hemagglutinin h1 x-181 |
|
22
|
124
|
5hytB |
Structure of human c4b-binidng protein alpha chain ccp domains 1 and 2 in complex with the hypervariable region of group a streptococcus m22 protein |
|
16
|
125
|
5hypA |
Structure of human c4b-binding protein alpha cain ccp domains 1 and 2 in complex with the hypervariable region of group a streptococcus m28 protein |
|
22
|
125
|
5i0qB |
Structure of human c4b-binding protein alpha chain ccp domains 1 and 2 in complex with the hypervariable region of mutant group a streptococcus m2 (k65a, n66a) protein |
|
18
|
125
|
5hzpB |
Structure of human c4b-binding protein alpha chain ccp domains 1 and 2 in complex with the hypervariable region of group a streptococcus m49 protein. |
|
21
|
125
|
5hyuB |
Structure of human c4b-binding protein alpha chain ccp domains 1 and 2 in complex with the hypervariable region of group a streptococcus m2 protein |
|
72
|
320
|
5hu8A |
The crystal structure of hemagglutinin from a/sichuan/26221/2014 (h5n6) influenza virus |
|
15
|
95
|
5hhdA |
Crystal structure of chemically synthesized heterochiral {rfx037 plus vegf-a} protein complex in space group p21 |
|
15
|
104
|
4uhzA |
Crystal structure of the human rgmb-bmp2 complex, crystal form 1 |
|
11
|
62
|
6ebxA |
Structure determination of a dimeric form of erabutoxin b, crystallized from thiocyanate solution |
|
174
|
552
|
6coxA |
Cyclooxygenase-2 (prostaglandin synthase-2) complexed with a selective inhibitor, sc-558 in i222 space group |
|
51
|
278
|
5cknA |
The cub1-egf-cub2 domains of rat mbl-associated serine protease-2 (masp-2) bound to ca2+ |
|
54
|
278
|
5cisA |
The cub1-egf-cub2 domains of rat mbl-associated serine protease-2 (masp-2) bound to ca2+ |
